Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
NVCR
#1985
NovoCure Limited - Ordinary Shares
17.8
2
USD
-0.01%
Market Price
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
-0.94%
Monthly Change
+17.31%
6 month change
+31.61%
Year Change
+29.60%
Previous Close
17.9
9
Open
17.8
2
Low
17.8
2
High
17.8
2
Volume
97
Markets
US Stock Market
Healthcare
Medical Devices
NVCR
1D
1W
1M
3M
6M
YTD
1Y
5Y
Open full chart
Financials
Overview
Statement
Statistics
Documents
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
Current
Key stats
Total common shares outstanding
102.41 M
104.42 M
105.46 M
107.09 M
109.92 M
113.79 M
116.45 M
Valuation ratios
Enterprise value
17.92 B
8.19 B
7.61 B
1.87 B
3.77 B
1.57 B
2.21 B
Price to earnings ratio
961.33
-134.07
-77.2
-7.38
-19.1
-10.6
-13.93
Price to sales ratio
38.11
14.51
13.22
3.01
5.31
2.2
2.94
Price to cash flow ratio
190.02
93.84
230.95
-20.89
-121.87
-29.4
-696.96
Price to book ratio
39.54
18.92
16.12
4.23
8.92
4.23
1.52
Enterprise value to EBITDA ratio
477.14
-214.58
-91.61
-8.29
-23.3
-11.17
-13.02
Profitability ratios
Return on assets %
0.02
-0.05
-0.08
-0.18
-0.14
-0.17
-0.02
Return on equity %
0.04
-0.14
-0.21
-0.57
-0.47
-0.4
-0.05
Return on invested capital %
105.03
-149.65
-317.14
-702.9
-111.43
-316.69
-21.54
Gross margin %
78.46
78.53
78.64
74.81
77.33
74.54
77.61
Operating margin %
6.15
-8.29
-16.64
-45.72
-28.17
-23.47
-5.75
EBITDA margin %
7.6
-7.14
-15.46
-44.3
-26.72
-21.48
-7.17
Net margin %
4.01
-10.91
-17.2
-40.65
-27.86
-20.79
-8.53
Liquidity ratios
Quick ratio
8.56
7.36
6.82
5.56
1.42
2.71
2.7
Current ratio
8.8
7.53
7
5.78
1.46
2.9
2.89
Inventory turnover
0.02
0.04
0.01
0
0.01
0.08
—
Asset turnover
0.65
0.49
0.46
0.44
0.51
0.64
0.23
Solvency ratios
Debt to assets ratio
0.41
0.49
0.47
0.5
0.08
0.24
0.25
Debt to equity ratio
0.9
1.37
1.28
1.57
0.27
0.57
0.58
Long term debt to total assets ratio
0.41
0.49
0.47
0.5
0.53
0.24
0.25
Long term debt to total equity ratio
0.9
1.37
1.28
1.57
1.82
0.57
0.58
Per share metrics
Operating cash flow per share
0.91
0.8
0.29
-0.69
-0.24
-0.44
-0.03
EBIT per share
0.28
-0.43
-0.86
-2.19
-1.58
-1.38
-1.37
EBITDA per share
0.34
-0.37
-0.79
-2.12
-1.5
-1.26
-1.5
Total debt per share
3.95
5.44
5.4
5.35
6.08
1.75
1.69
Cash per share
7.74
9.07
9.26
8.56
8.9
4.02
3.8
Net current asset value per share
9.18
10.38
10.62
9.72
10.26
5.8
5.5
Tangible book value per share
4.38
3.97
4.22
3.41
3.34
3.05
2.91
Working capital per share
8.14
9
9.1
8.04
3.25
3.8
3.6
Book value per share
4.38
3.97
4.22
3.41
3.34
3.05
2.91
News
Wall Street Analysts See a 50.86% Upside in NovoCure (NVCR): Can the Stock Really Move This High?
Are You Looking for a Top Momentum Pick? Why NovoCure (NVCR) is a Great Choice
Wall Street Analysts Think NovoCure (NVCR) Could Surge 53.68%: Read This Before Placing a Bet
4 Healthcare Stocks to Watch as Defensive Demand Strengthens
NovoCure (NVCR) Upgraded to Buy: What Does It Mean for the Stock?
Wall Street Analysts Believe NovoCure (NVCR) Could Rally 46.63%: Here's is How to Trade
Unlocking NovoCure (NVCR) International Revenues: Trends, Surprises, and Prospects
NovoCure: Why I’m Fading The Q2 Earnings Rally (NASDAQ:NVCR)
NovoCure Limited 2026 Q2 - Results - Earnings Call Presentation (NASDAQ:NVCR) 2026-07-24
NovoCure Limited (NVCR) Q2 2026 Earnings Call Transcript
Novocure Flashes A Bullish Signal As It Breaks Out. Have Shares 'Turned A Corner?'
NovoCure (NVCR) Reports Q2 Loss, Beats Revenue Estimates